An interventional study of Hard occlusal splint and Flexible customized mouthguard in Satisfaction, sponsored by University of Barcelona. Status unknown at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-03-22.
Sponsored by University of Barcelona · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Personal Satisfaction with a site in Spain — 5 open to participants now, 5 under way, none of them phase 3. Personal Satisfaction · Spain.
Among the 24 studies in Personal Satisfaction with a site in Spain, this one is the 16th largest by planned enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2019, is one of 14 with no phase, and was the 15th registered.
543 studies on the registry are indexed under Personal Satisfaction; 91 are open to participants now.
Browse Personal Satisfaction studies →5 of the 24 studies in Personal Satisfaction with a site in Spain are open now. Recruiting first, the newest first:
University of Barcelona · Sites in Spain
Ages 16–29
Centre Besai · Sites in Spain
Ages 14–18 · Healthy volunteers
University of Seville · Sites in Spain
Healthy volunteers
Universidad Rey Juan Carlos · Sites in Spain
Ages 18+
University of Vic - Central University of Catalonia · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 38 Personal Satisfaction studies recruiting now, 18 (47%) set no upper age limit and 15 (39%) stop at 75 or younger; 8 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 31 is below the median of 93 across 418 interventional studies indexed under Personal Satisfaction.
Median enrollment 96 across the 19 interventional studies, 700 across the 5 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 24 have an industry lead sponsor. The 10 most frequent:
University of Barcelona is the lead sponsor of 100 studies on the registry; 30 are open to participants now.
University of Barcelona has 4 studies filed under Personal Satisfaction — fewer than ten, so there is no comparison to draw.
1 of the studies in Personal Satisfaction with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06384196University of BarcelonaIdentity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression | 2027-06-30 |
Add it to your calendar (.ics) → With an account.
Among the 24 studies in Personal Satisfaction with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study assesses to determine the most effective type of device on the degree of satisfaction of patients with amyotrophic lateral sclerosis for managing oral self-biting injuries. Thirty-one patients with amyotrophic lateral sclerosis will wear two devices, a hard occlusal splint (HOS) and a flexible customized mouthguard (FCM), for two weeks each one. The sequence will be randomized to obtain one-half of the participants starting the first week wearing the HOS, and the other half wearing the FCM. The participants will rate the degree of satisfaction with the device and the degree of improvement or worsening of oral self-biting injuries in a 10-point scale. They will also rate the degree of change in their quality of life because of changes in their oral self-biting injuries. Finally they will rate the compliance and report the adverse effects.
This crossover intervention study aims to assess the most effective type of device on the degree of satisfaction of patients with amyotrophic lateral sclerosis for managing oral self-biting injuries. Thirty-one patients with amyotrophic lateral sclerosis diagnosed in the ALS Functional Unit at Bellvitge University Hospital will participate in this randomized crossover trial. Two devices will be prepared for each patient, a hard occlusal splint (HOS) and a flexible customized mouthguard (FCM). They will wear one type of device for the first two weeks, followed by a week off, and the other type of device for the fourth and fifth week. The sequence will be randomized to obtain one-half of the participants starting the first week wearing the HOS, and the other half wearing the FCM. The participants will rate the degree of satisfaction with the device in a 10-point scale, considering 0 extremely dissatisfied and 10 completely satisfied, and the degree of improvement or worsening of oral self-biting injuries, considering 0 an extreme worsening and 10 completely improved. They will also rate the degree of change in their quality of life (nothing, a bit, quite, a lot) because of changes in their oral self-biting injuries. Finally they will rate the compliance as the percentage of time the device was used with respect to the recommended time and report the adverse effects (excessive salivation, dry mouth, tooth pain, mucosal irritation, temporomandibular joint (TMJ) pain, TMJ sounds, bite change, other).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Use of a hard occlusal splint (HOS) for the first two weeks, followed by a week off, and a flexible customized mouthguard (FCM) for the fourth and fifth week.
Device: Hard occlusal splint · Device: Flexible customized mouthguard
Use of a flexible customized mouthguard (FCM) for the first two weeks, followed by a week off, and a hard occlusal splint (HOS) for the fourth and fifth week.
Device: Hard occlusal splint · Device: Flexible customized mouthguard
Use of a hard occlusal splint at times they considered helpful.
Use of a flexible customized mouthguard at times they considered helpful.
Degree of satisfaction using a questionnarie
Participant satisfaction will be assessed by asking the question "How satisfied are you with the device?" using a 0-10 point scale (considering 0= extremely dissatisfied and 10 = completely satisfied)
Time frame: 1-2 weeks
Degree of improvement or worsening of oral self-biting injuries using a questionnarie
The degree of improvement or worsening of oral self-biting injuries while using the device will be assessed by asking the question "How much do you think wearing the device improves the oral self-biting injuries?" using a 0-10 point scale (considering 0= extreme worsening to 10= completely improved).
Time frame: 1-2 weeks
Degree of change in their quality of life using a questionnaire
The degree of change in their quality of life while using the device because of changes in their oral self-biting injuries will be assessed by asking the question "How much do you think wearing the device improves your quality of life?" using a 4-point scale (considering 0 = nothing, 1 = a bit, 2 = quite, 4 = a lot).
Time frame: 1-2 weeks
Compliance
Participants compliance using the device will be assessed as the percentage of time the device was used with respect to the recommended time.
Time frame: 1-2 weeks
Adverse effects
The adverse effects related to use of the device will be recorded (excessive salivation, dry mouth, tooth pain, mucosal irritation, temporomandibular joint (TMJ) pain, TMJ sounds, bite change, other).
Time frame: 1-2 weeks
Willingness to pay
Participants willingness to pay will be assessed by asking the question "What is the maximum you would pay for the device?"
Time frame: 1-2 weeks
Started Nov 2019 (actual). Primary completion is estimated for Sep 2021, 22 months after the start.
Of 250 non-industry interventional studies with no phase under Personal Satisfaction, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's planned 22 months is above that.
Counting every sponsor, half of 257 studies reached it within 9 months; a quarter within 3 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.